全文获取类型
收费全文 | 896篇 |
免费 | 200篇 |
国内免费 | 73篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 6篇 |
妇产科学 | 87篇 |
基础医学 | 103篇 |
口腔科学 | 5篇 |
临床医学 | 79篇 |
内科学 | 180篇 |
皮肤病学 | 52篇 |
神经病学 | 24篇 |
特种医学 | 10篇 |
外科学 | 158篇 |
综合类 | 95篇 |
预防医学 | 71篇 |
眼科学 | 13篇 |
药学 | 34篇 |
中国医学 | 6篇 |
肿瘤学 | 241篇 |
出版年
2024年 | 3篇 |
2023年 | 23篇 |
2022年 | 47篇 |
2021年 | 59篇 |
2020年 | 60篇 |
2019年 | 65篇 |
2018年 | 59篇 |
2017年 | 67篇 |
2016年 | 113篇 |
2015年 | 104篇 |
2014年 | 142篇 |
2013年 | 103篇 |
2012年 | 107篇 |
2011年 | 85篇 |
2010年 | 59篇 |
2009年 | 52篇 |
2008年 | 11篇 |
2007年 | 7篇 |
2006年 | 1篇 |
2004年 | 1篇 |
2000年 | 1篇 |
排序方式: 共有1169条查询结果,搜索用时 156 毫秒
21.
22.
As a mechanical and exogenous stimulus, exercise training induces cardiac physiological hypertrophy, and the cardiac structure is changed slowly, steadily and coordinately. Simultaneously, energy metabolism and function of the cardiac muscle are also improved. These are positive adaptations in the heart when experiencing endurance exercise training. Recently, angiotensin Ⅱ type 1 (AT1) receptor, autophagy and miRNAs are all considered as important regulators to cardiac hypertrophy induced by exercise training at different molecular levels. Fully understanding the relations and the important role of AT1 receptor, autophagy and miRNAs in cardiac physiological hypertrophy will further enrich the signaling pathway of cardiac hypertrophy induced by exercise training. 相似文献
23.
Eric Gustavo Ramírez-Salazar Luis Carlos Salinas-Silva Maria Eugenia Vázquez-Manríquez Luis Vicente Gayosso-Gómez Maria Cristina Negrete-Garcia Sandra Lizbeth Ramírez-Rodriguez Raúl Chávez Edgar Zenteno Patricio Santillán Javier Kelly-García Blanca Ortiz-Quintero 《Experimental and molecular pathology》2014
24.
Jae Youn Cheong Hyoung Doo Shin Sung Won Cho Yoon Jun Kim 《Journal of Korean medical science》2014,29(11):1523-1527
MicroRNA polymorphisms may be associated with carcinogenesis or immunopathogenesis of infection. We evaluated whether the mircoRNA-604 (miR-604) polymorphism can affect the persistence of hepatitis B virus (HBV) infection, and the development to hepatocellular carcinoma (HCC) in patients with chronic HBV infection. A total of 1,439 subjects, who have either past or present HBV infection, were enrolled and divided into four groups (spontaneous recovery, chronic HBV carrier without cirrhosis, liver cirrhosis and HCC). We genotyped the precursor miR-604 genome region polymorphism. The CC genotype of miR-604 rs2368392 was most frequently observed and T allele frequency was 0.326 in all study subjects. The HBV persistence after infection was higher in those subjects with miR-604 T allele (P=0.05 in a co-dominant and dominant model), which implied that the patients with miR-604 T allele may have a higher risk for HBV chronicity. In contrast, there was a higher rate of the miR-604 T allele in the chronic carrier without HCC patients, compared to those of the HCC patients (P=0.03 in a co-dominant model, P=0.02 in a recessive model). The T allele at miR-604 rs2368392 may be a risk allele for the chronicity of HBV infection, but may be a protective allele for the progression to HCC in chronic HBV carriers.
Graphical Abstract
相似文献25.
Gastric cancer is the fourth most common cancer in the world and the second leading cause of cancerrelated death.More than 80%of diagnoses occur at the middle to late stage of the disease,highlighting an urgent need for novel biomarkers detectable at earlier stages.Recently,aberrantly expressed microRNAs(miRNAs)have received a great deal of attention as potential sensitive and accurate biomarkers for cancer diagnosis and prognosis.This review summarizes the current knowledge about potential miRNA biomarkers for gastric cancer that have been reported in the publicly available literature between 2008 and 2013.Available evidence indicates that aberrantly expressed miRNAs in gastric cancer correlate with tumorigenesis,tumor proliferation,distant metastasis and invasion.Furthermore,tissue and cancer types can be classified using miRNA expression profiles and next-generation sequencing.As miRNAs in plasma/serum are well protected from RNases,they remain stable under harsh conditions.Thus,potential functions of these circulating miRNAs can be deduced and may implicate their diagnostic value in cancer detection.Circulating miRNAs,as well as tissue miRNAs,may allow for the detection of gastric cancer at an early stage,prediction of prognosis,and monitoring of recurrence and/or lymph node metastasis.Taken together,the data suggest that the participation of miRNAs in biomarker development will enhance the sensitivity and specificity of diagnostic and prognostic tests for gastric cancer. 相似文献
26.
27.
microRNAs是一类非编码小RNAs分子,新近发现其具有重要的调节基因表达的功能,它能通过抑制翻译和降解靶mRNA来负性调控转录后水平的基因表达,miRNAs已经被证实在肌肉发育和肌细胞增殖和分化的调节中具有重要作用。最近研究发现,肌肉特异性转录因子控制一些microRNAs的表达,通过多种机制调节肌肉发育和功能。结合信息学、生物化学和遗传基因学方法,不仅将阐明骨骼肌microRNAs调控网络,更好地理解肌肉组织的调节,还将通过鉴定候选microRNAs的潜在临床应用靶点,增加肌肉营养不良的治疗干预的新机会。 相似文献
28.
microRNAs(miRNAs)是一类长约18-25个核苷酸序列的内源性非编码单链小RNA,通过与靶基因序列特异性相互作用,在转录后水平调节基因表达,从而调控细胞增殖、分化与凋亡等过程.大量研究表明,miRNAs参与肝脏的多种生理和病理过程.本文就近年来miRNAs在肝再生(liver regeneration,LR)、肝脏免疫反应、肝纤维化及肝癌(hepato cellular carcinoma,HCC)形成这4个过程中的作用的研究作一综述. 相似文献
29.
作为非编码RNA (ncRNAs)的一种,微小RNA(microRNA,miRNA)在基因表达调控方面受到广泛关注.MiRNA参与细胞周期、细胞凋亡、细胞迁移等进程,在肿瘤发生发展过程中也发挥重要作用.中国胃癌发病率较高,但对胃癌的治疗未能取得突破性进展,进展期胃癌患者往往预后不佳.目前尚缺乏可对胃癌患者预后进行判断的有效生物学标志,胃癌耐药也是临床的棘手问题.如何根据有效的生物学标志来判断预后,并针对这些靶点展开治疗,如何改善胃癌化疗耐药问题.miRNA在基因调控方面的作用给攻破这些难题带来了可能.该文是近年来关于miRNA与胃癌患者预后关系,改善患者预后,化疗耐药调控等方面的最新研究的综合论述. 相似文献
30.
腹主动脉瘤(AAA)是一种病死率极高的急症,因发病机制复杂,至今病因尚未明确。近年来研究发现,去整合素和金属蛋白酶(ADAM)家族参与促进炎性因子的释放、细胞外基质降解等特性可能与AAA发病有关;mi RNA在血管平滑肌细胞中特异性表达并通过信号通路调节其增殖和凋亡、靶向调控炎性细胞分化和炎性因子的释放、调节细胞外基质蛋白表达等可能也参与调节AAA发病。笔者就ADAM10和ADAM17在AAA发病机制中作用和mi RNA对AAA发病调节做一综述。 相似文献